FGF-CX polynucleotide sequences and methods of producing same

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7291483
APP PUB NO 20050208540A1
SERIAL NO

11027948

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides FGF-CX, a novel isolated polypeptide, as well as a polynucleotide encoding FGF-CX and antibodies that immunospecifically bind to FGF-CX or any derivative, variant, mutant, or fragment of the FGF-CX polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the FGF-GX polypeptide, polynucleotide and antibody are used in detection and treatment of a broad range of pathological states, as well as to other uses.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CURAGEN CORPORATIONNEW HAVEN CT 06511

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Prayaga, Sudhirdas K Chesterfield, MO 28 85
Shimkets, Richard A West Haven, CT 162 947

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation